跳至主要内容
临床试验/DRKS00032532
DRKS00032532招募中不适用

Prospective, multi-centre, non-interventional study on the use, tolerability and safety of the One Strength dose escalation scheme with NOVo Helisen® hoUSe dust mites in everyday practice - NOVUS

Allergopharma GmbH & Co. KG0 个研究点目标入组 1,000 人开始时间: 2023年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 Years 至 one(—)
性别
All

入选标准

  • 1. Written informed consent from the patient. In the case of patients under the age of 18, the consent of both parents/legal guardians is also required.
  • 2. Patients treatment with the One-Strength dose escalation scheme of NH (D.p./D.f.) must be approved, in accordance with the specifications of the SmPC. This includes adolescents (=12 and <18 years) and adults with allergic (IgE-mediated) diseases such as allergic rhinitis, allergic conjunctivitis, allergic bronchial asthma (see section 4 of the current SmPC).
  • 3. The therapy decision must precede the decision to participate in the study and must be independent.

排除标准

  • 1. Any contraindication according to section 4.3 of the current SmPC for NH (D.p./D.f.) for the One-Strength dose escalation scheme.

研究者

相似试验

已完成
不适用
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practiceG35.1
DRKS00029567Biogen GmbH118
进行中(未招募)
4 期
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.
CTRI/2017/10/010218ovo Nordisk India Private Ltd
已完成
不适用
A multicenter, prospective, non-interventional observational study to determine LDL-C goal attainment rate in elderly patients with dyslipidemia receiving Mevalotin® Tab.
KCT0003190Daiichi-Sankyo Korea3,000
尚未招募
4 期
A Non-interventional, observational Post Marketing Surveillance (PMS) Study of AdaliRelTM (Adalimumab) in Patients With Active Rheumatoid arthritis.
CTRI/2020/04/024644Reliance Life Sciences Pv Ltd
招募中
不适用
Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation in Japanese Clinical Practiceon-valvular atrial fibrillation (In the present study, non-valvular atrial fibrillation refers to atrial fibrillation without a history of prosthetic valve replacement or mitral valve stenosis.)
JPRN-UMIN000009376Tohoku University School of Medicine7,000